pindolol has been researched along with Migraine Disorders in 7 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patient took 20 mg daily for five days and then decided, on her own, to decrease the dosage after experiencing insomnia, a common adverse effect of duloxetine." | 1.34 | Facial flushing associated with duloxetine use. ( Ezzo, DC; Patel, PN, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ezzo, DC | 1 |
| Patel, PN | 1 |
| Koch-Weser, J | 1 |
| Frishman, WH | 1 |
| Jackson, EA | 1 |
| Sullman, SA | 1 |
| Anthony, M | 2 |
| Schoenen, J | 1 |
| Delwaide, PJ | 1 |
| Saxena, PR | 1 |
| Heiligers, JP | 1 |
| Villalón, CM | 1 |
| Ferrari, MD | 1 |
| Lance, JW | 1 |
| Somerville, B | 1 |
2 reviews available for pindolol and Migraine Disorders
| Article | Year |
|---|---|
beta-Adrenoceptor antagonists: new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Me | 1981 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; | 1984 |
1 trial available for pindolol and Migraine Disorders
| Article | Year |
|---|---|
[Indications for beta-blockers in neurology].
Topics: Alcoholism; Antiparkinson Agents; Anxiety; Clinical Trials as Topic; Drug Therapy, Combination; Huma | 1978 |
4 other studies available for pindolol and Migraine Disorders
| Article | Year |
|---|---|
Facial flushing associated with duloxetine use.
Topics: Adult; Botulinum Toxins, Type A; Capsules; Duloxetine Hydrochloride; Female; Flushing; Humans; Migra | 2007 |
Beta-blockers in migraine prophylaxis.
Topics: Adrenergic beta-Antagonists; Humans; Migraine Disorders; Pindolol; Propranolol | 1978 |
Effects of tertatolol, a beta-adrenoceptor antagonist with agonist affinity at 5-HT1A receptors, in an animal model of migraine: comparison with propranolol and pindolol.
Topics: Adrenergic beta-Antagonists; Animals; Carotid Arteries; Disease Models, Animal; Hemodynamics; Inject | 1992 |
A comparative trial of prindolol, clonidine and carbamazepine in the interval therapy of migraine.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Animals; Anticonvulsants; Antihypertensive Age | 1972 |